Stopping anti-CMV therapy may be safe option for some HIV patients [news] NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Stopping anti-CMV therapy may be safe option for some HIV patients [news]

Am J Health Syst Pharm. 2000 Jan 1;57(1):21. Unique Identifier : AIDSLINE MED/20094248


Keywords: NEWS JOURNAL ARTICLE Anti-HIV Agents/*THERAPEUTIC USE Cytomegalovirus Retinitis/ETIOLOGY/*PREVENTION & CONTROL Human HIV Infections/COMPLICATIONS/*DRUG THERAPY

KWDnewsjournalarticleanti-hivagents/KWDtherapeuticusecytomegalovirusretinitis/etiology/KWDprevention&controlhumanhivinfections/complications/KWDdrugtherapy
000430
A0040911


Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .